Scientists at the University of Eastern Finland have investigated the effects of predisposing Alzheimer's disease (AD) mutations in induced pluripotent stem cell (iPSC)-derived microglia (iMGLs), and they found that APOE4 mutations had a much stronger effect that either presenilin (PSEN) or amyloid precursor protein (APP) in that cell type.